Stem Cell Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Stem Cell Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cord Blood
Reports from Seoul National University highlight recent research in cord blood
June 15th, 2009
"Background aims Mesenchymal stromal cells (MSC) have been studied intensively in regenerative medicine. However, their therapeutic potential against tumor formation and cancer metastasis is still unclear," scientists in Seoul, South Korea report. "The effects of transplantation of MSCs in early-stage of carcinogenesis, should be evaluated. MSC isolated from human umbilical cord blood (UCB) and adipose tissue (AD) were transplanted in a mouse cancer metastasis model. The effects of MSC on tumor growth and metastasis were analyzed. The effects of transplantation of MSC into the mouse model at very early stage carcinogenesis were also evaluated. Human MSC reduced lung...
Source: Stem Cell Week (2009-06-15)
|
